BACKGROUND: Current prescribing information recommends that physicians apply a dose ratio of 1.37:1 (1.53:1 prior to January 2015) in the United States (US) when switching patients with primary ...
Maclean et al. 6 used the statistical techniques described by us 3 to confirm that the CD34+ cell dose based on IBW correlated better with engraftment than that based on ABW, but felt that this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback